image
Healthcare - Biotechnology - NASDAQ - US
$ 3.19
0.315 %
$ 56.7 M
Market Cap
-0.44
P/E
CASH FLOW STATEMENT
-27.9 M OPERATING CASH FLOW
30.58%
14.5 M INVESTING CASH FLOW
201.57%
17.8 M FINANCING CASH FLOW
-67.85%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis BioVie Inc.
image
Net Income -32.1 M
Depreciation & Amortization 229 K
Capital Expenditures 0
Stock-Based Compensation 4.66 M
Change in Working Capital -86.8 K
Others -714 K
Free Cash Flow -27.9 M

Cash Flow

Millions
Jun-2024 Jun-2023 Jun-2022 Jun-2021 Jun-2020 Jun-2019 Jun-2018 Jun-2017 Jun-2016 Jun-2015 Jun-2014 Jun-2013
OPERATING CASH FLOW
Net Income (32.1) (50.3) (26.1) (130.2) (16.7) (2.4) (2.4) (1.3) (0.4) (0.2) (0.3) 70 K
Depreciation & Amortization 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 51 K 0 0 0
Deferred Income Tax 0 (1 033.5) 0 (8.3) 9.2 51.4 K 0 0 4.91 K 0 0 0
Stock Based Compensation 4.7 6.4 6.2 3.0 24.8 K 64.9 K 0.9 92.1 K 7.88 K 7.5 K 2.59 K 0
Other Operating Activities (0.6) 1 037.1 (2.1) 124.9 4.8 49 K 26.5 K 0.6 10 K 7.5 K 2.59 K 60 K
Change in Working Capital 86.8 K (0.3) 2.8 19.5 K 0.8 (0.5) 0.6 0.4 0.2 0.2 0.1 0
Cash From Operations (27.9) (40.3) (19.0) (10.5) (1.6) (2.5) (0.6) (0.6) (0.2) 65.4 K (0.2) 10 K
INVESTING CASH FLOW
Capital Expenditures 0 0 0 0 0 0 0 0 0 0 0 0
Other Items 14.5 (14.3) 0 0 0 0 0 0 9.91 K 0 0 0
Cash From Investing Activities 14.5 (14.3) 0 0 0 0 0 0 9.91 K 0 0 0
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 (1.1) 0 0 5 0 0 0
Total Debt Repaid (10.0) 0 14.6 (1.4) 1.3 (0.2) 35 K 0 0 0 0 0
Dividends Paid 0 0 0 0 (17.1) 48.7 K 0 0 0 0 0 0
Other Financing Activities 0 2.24 K 18.5 0.7 0 6.1 0.5 0.5 0 0 0 2.0
Cash From Financing Activities 17.8 55.4 33.1 14.9 1.3 2.8 0.7 0.5 5 0 0 2.0
CHANGE IN CASH
Net Change In Cash 4.4 0.8 14.1 4.5 (0.3) 0.3 40.7 K (0.1) (0.1) 65.4 K (0.2) 2.0
FREE CASH FLOW
Free Cash Flow (27.9) (40.3) (19.0) (10.5) (1.6) (2.5) (0.6) (0.6) (0.2) 65.4 K (0.2) 10 K